Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.54
-0.03 (-1.91%)
At close: Apr 29, 2025, 3:59 PM
1.56
1.30%
After-hours: Apr 29, 2025, 06:17 PM EDT
Allogene Therapeutics Revenue
Allogene Therapeutics reported an annual revenue of $22K, reflecting a -76.84% growth. For the quarter ending December 31, 2024, Allogene Therapeutics generated $0 in revenue.
Revenue (ttm)
$22K
Revenue Growth
-76.84%
Price / Sales Ratio
18861.32
Revenue / Employee
$97.35
Employees
226
Market Cap
334.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 22K | -76.84% |
| Dec 31, 2023 | 95K | -60.91% |
| Dec 31, 2022 | 243K | -99.37% |
| Dec 31, 2021 | 38.49M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |